Final Jeopardy | Final Jeopardy |
---|---|
What is Gemtuzamab?
This agent is added to standard IC therapy for patients with a core binding abnormality.
|
What is False (below 0.5 is not so bad)
T/F Question: The ELN guidelines, which clearly state the 0.5 allelic ratio, they state that above 0.5 is bad and below 0.5 is waaay worse.
|
What is TP53?
This molecular mutation has a very poor prognosis with standard IC.
|
What is Cytogenetic?
Ther Geman study pointed out that its more important to get the molecular, the FISH and _____ information.
|
What is Moffitt Cancer Center?
The institution where Dr. Rami Komrokji practices.
|
What is VAF (Variant allele frequency)?
This is used to measure the relative burden of disease.
|
What is there is no standard definition of fitness?
This is considered a necessary part of assessing the definition of fitness for IC or transplant.
|
What is end-of-cycle 1 marrow?
Dr. Naval stated that this is very important when treating patients in the community at managing potential VEN toxicities.
|
What is False
T/F Question: Standard IC is the best option for all fit patients with AML
|
What is breaks in treatment?
Dr. Pollyea stated early marrow and this is important for patients after achieving remission on Venetoclax.
|